Winton Group’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,751
Closed -$456K 1090
2025
Q4
$456K Buy
16,751
+351
+2% +$12.3K 0.02% 654
2025
Q3
$658K Buy
+16,400
New +$617K 0.02% 536
2023
Q2
Sell
-23,865
Closed -$548K 761
2023
Q1
$548K Buy
23,865
+2,435
+11% +$64.7K 0.03% 654
2022
Q4
$602K Buy
21,430
+19
+0.1% +$535 0.04% 576
2022
Q3
$606K Sell
21,411
-5,529
-21% -$148K 0.04% 584
2022
Q2
$597K Buy
26,940
+4,802
+22% +$108K 0.03% 641
2022
Q1
$644K Buy
22,138
+3,382
+18% +$103K 0.03% 608
2021
Q4
$617K Sell
18,756
-11,756
-39% -$473K 0.04% 618
2021
Q3
$1.41M Buy
30,512
+10,947
+56% +$529K 0.08% 335
2021
Q2
$1.08M Buy
19,565
+4,765
+32% +$266K 0.06% 490
2021
Q1
$764K Sell
14,800
-2,108
-12% -$104K 0.04% 623
2020
Q4
$733K Sell
16,908
-36,441
-68% -$1.44M 0.05% 578
2020
Q3
$1.87M Buy
53,349
+22,548
+73% +$988K 0.06% 561
2020
Q2
$1.65M Buy
30,801
+24,923
+424% +$1.15M 0.04% 743
2020
Q1
$209K Buy
+5,878
New +$272K 0.01% 1242
2019
Q4
Sell
-10,790
Closed -$350K 1523
2019
Q3
$350K Buy
+10,790
New +$447K ﹤0.01% 1219

Other funds holding AGIO